National Academy of Sciences
References
271. Maskell C, et al. Dietary intake after pancreatectomy.
British Journal of Surgery 1999, 86/3 (323-326).
272. Backovic D, et al. Environmental factors, health-related
habits, and serum selenium levels in cancer patients and
healthy controls. Biological Trace Element Research 1999,
67/1 (55-62).
273. Dodge M.L., et al. Selenium supplementation increases
the polyunsaturated fatty acid content of human breast milk .
Journal of Trace Elements in Experimental Medicine 1999, 12/1
(37-44).
274. Jiang C, et al. Selenium-induced inhibition of
angiogenesis in mammary cancer at chemopreventive levels of
intake. Mol Carcinog 1999 Dec;26(4):213-25.
275. Funke AM. [Potential of selenium in gynecologic
oncology]. Med Klin 1999 Oct 15;94 Suppl 3:42-4.
276. [Role of sodium selenite as an adjuvant in radiotherapy
of rectal carcinoma]. [Article in German] Med Klin 1997 Sep
15;92 Suppl 3:48-9.
277. Psathakis D, et al. Blood selenium and glutathione
peroxidase status in patients with colorectal cancer. Dis
Colon Rectum 1998 Mar;41(3):328-35.
278. Vucelic B, et al. [Differences in serum selenium
concentration in probands and patients with colorectal
neoplasms in Zagreb, Croatia]. Acta Med Austriaca
1994;21(1):19-23.
279. Surg Oncol, 2000 Mar, 18:2, 100-5.
280. Combs GF Jr.Chemopreventive mechanisms of selenium. Med
Klin 1999 Oct 15;94 Suppl 3:18-24.
281. Clark LC, et al. Decreased incidence of prostate cancer
with selenium supplementation: results of a double-blind
cancer prevention trial. Br J Urol 1998
May;81(5):730-4.
282. Decensi A, et al. Recent advances in cancer
chemoprevention, with emphasis on breast and colorectal
cancer. Eur J Cancer 2000 Apr 1;36(6):694-709.
283. Combs GF Jr, et al. Reduction of cancer risk with an
oral supplement of selenium. Biomed Environ Sci 1997
Sep;10(2-3):227-34.
284. Combs GF Jr, et al. Reduction of cancer mortality and
incidence by selenium supplementation. Med Klin 1997 Sep
15;92 Suppl 3:42-5.
285. Yang CS. Vitamin nutrition and gastroesophageal cancer.
J Nutr 2000 Feb;130(2S Suppl):338S-339S.
286. Clark LC, et al. Plasma selenium concentration predicts
the prevalence of colorectal adenomatous polyps. Cancer
Epidemiol Biomarkers Prev 1993 Jan-Feb;2(1):41-6.
287. Clark LC, et al. Selenium in forage crops and cancer
mortality in U.S. counties. Arch Environ Health 1991
Jan-Feb;46(1):37-42.
288. Schrauzer GN. Selenium and cancer: a review. Bioinorg
Chem 1976;5(3):275-81.
289. Yu MW, et al. Plasma selenium levels and risk of
hepatocellular carcinoma among men with chronic hepatitis
virus infection. Am J Epidemiol 1999 Aug
15;150(4):367-74.
290. Berkson BM. A conservative triple antioxidant approach
to the treatment of hepatitis C. Combination of alpha lipoic
acid (thioctic acid), silymarin, and selenium: three case
histories. Med Klin 1999 Oct 15;94 Suppl 3:84-9.
291. Look MP, et al. Interferon/antioxidant combination
therapy for chronic hepatitis C--a controlled pilot trial.
Antiviral Res 1999 Sep;43(2):113-22.
292. Baum MK, et al. High risk of HIV-related mortality is
associated with selenium deficiency. J Acquir Immune Defic
Syndr Hum Retrovirol 1997 Aug 15;15(5):370-4.
293. Chandra RK. Effect of vitamin and trace-element
supplementation on immune responses and infection in elderly
subjects. Lancet 1992 Nov 7;340(8828):1124-7.
294. Girodon F, et al. Effect of micronutrient
supplementation on infection in institutionalized elderly
subjects: a controlled trial. Ann Nutr Metab
1997;41(2):98-107.
295. Nenci GG, et al. [Diabetes, coagulation and vascular
events]. Recenti Prog Med 2000 Feb;91(2):86-90.
296. Sharma A, et al. Evaluation of oxidative stress before
and after control of glycemia and after vitamin E
supplementation in diabetic patients. Metabolism 2000
Feb;49(2):160-2.
297. Ferber P, et al. High dose supplementation of
RRR-alpha-tocopherol decreases cellular hemostasis but
accelerates plasmatic coagulation in type 2 diabetes
mellitus. Horm Metab Res 1999 Dec;31(12):665-71.
298. Paolisso G, et al. Chronic vitamin E administration
improves brachial reactivity and increases intracellular
magnesium concentration in type II diabetic patients.
J Clin Endocrinol Metab 2000 Jan;85(1):109-15.
299. Kaneto H, et al. Beneficial effects of antioxidants in
diabetes: possible protection of pancreatic beta-cells
against glucose toxicity. Diabetes 1999
Dec;48(12):2398-406.
300. Anderson JW, et al. Antioxidant supplementation effects
on low-density lipoprotein oxidation for individuals with
type 2 diabetes mellitus. J Am Coll Nutr 1999
Oct;18(5):451-61.
301. Ferreira FM, et al. Decreased susceptibility to lipid
peroxidation of Goto-Kakizaki rats: relationship to
mitochondrial antioxidant capacity. Life Sci
1999;65(10):1013-25.
302. Skrha J, et al. Insulin action and fibrinolysis
influenced by vitamin E in obese Type 2 diabetes mellitus.
Diabetes Res Clin Pract 1999 Apr;44(1):27-33.
303. Gazis A, et al. Effect of oral vitamin E
(alpha-tocopherol) supplementation on vascular endothelial
function in Type 2 diabetes mellitus. Diabet Med 1999
Apr;16(4):304-11.
304. Davi G, et al. In vivo formation of 8-iso-prostaglandin
f2alpha and platelet activation in diabetes mellitus: effects
of improved metabolic control and vitamin E supplementation.
Circulation 1999 Jan 19;99(2):224-9.
305. Tutuncu NB, et al. Reversal of defective nerve
conduction with vitamin E supplementation in type 2 diabetes:
a preliminary study. Diabetes Care 1998
Nov;21(11):1915-8.
306. Chung TW, et al. Reducing lipid peroxidation stress of
erythrocyte membrane by alpha-tocopherol nicotinate plays an
important role in improving blood rheological properties in
type 2 diabetic patients with retinopathy. Diabet Med 1998
May;15(5):380-5
307. Yoshida H, et al. Vitamin E/lipid peroxide ratio and
susceptibility of LDL to oxidative modification in
non-insulin-dependent diabetes mellitus. Arterioscler Thromb
Vasc Biol 1997 Jul;17(7):1438-46.
308. Reaven P. Dietary and pharmacologic regimens to reduce
lipid peroxidation in non-insulin-dependent diabetes
mellitus. Am J Clin Nutr 1995 Dec;62(6
Suppl):1483S-1489S.
309. Salonen JT, et al. Increased risk of non-insulin
dependent diabetes mellitus at low plasma vitamin E
concentrations: a four year follow up study in men. BMJ 1995
Oct 28;311(7013):1124-7.
310. Caballero B. Vitamin E improves the action of insulin.
Nutr Rev 1993 Nov;51(11):339-40.
311. Balabolkin MI, et al. [Effect of high doses of
tocopherol on the processes of lipid peroxidation and insulin
secretion in patients with non-insulin-dependent diabetes
mellitus]. [Article in Russian] Probl Endokrinol (Mosk) 1994
May-Jun;40(3):10-2.
312. Meydani SN, Vitamin E and Immunity. JAMA (1997 May 7)
277(17):1380-6.
313. Meydani M, et al. The effect of long-term dietary
supplementation with antioxidants. Ann N Y Acad Sci 1998 Nov
20;854:352-60.
314. Gey KF Vitamins E plus C and interacting conutrients
required for optimal health. A critical and constructive
review of epidemiology and supplementation data regarding
cardiovascular disease and cancer. Biofactors
1998;7(1-2):113-74.
315. Sokoloski JA, et al. Induction of the differentiation of
HL-60 promyelocytic leukemia cells by vitamin E and other
antioxidants in combination with low levels of vitamin D3:
possible relationship to NF-kappaB. Leukemia 1997
Sep;11(9):1546-53
316. Swain RA, et al. Therapeutic uses of vitamin E in
prevention of atherosclerosis. Altern Med Rev 1999
Dec;4(6):414-23.
317. Wu D, et al. Effect of vitamin E on human aortic
endothelial cell production of chemokines and adhesion to
monocytes. Atherosclerosis 1999 Dec;147(2):297-307.
318. Davey PJ, et al. Cost-effectiveness of vitamin E therapy
in the treatment of patients with angiographically proven
coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant
Study. Am J Cardiol 1998 Aug 15;82(4):414-7.
319. Polasek J. Acetylsalicylic acid and vitamin E in
prevention of arterial thrombosis. Can J Cardiol 1997
May;13(5):533-5.
320. Hoogwerf BJ, et al. The HOPE study. Ramipril lowered
cardiovascular risk, but vitamin E did not. Cleve Clin J Med
2000 Apr;67(4):287-93.
321. Matthai J. Vitamin E updated. Indian J Pediatr 1996
Mar-Apr;63(2):242-53.
322. Floreani A, et al. Plasma antioxidant levels in chronic
cholestatic liver diseases. Aliment Pharmacol Ther 2000
Mar;14(3):353-8.
323. Watson JP, et al. Case report: oral antioxidant therapy
for the treatment of primary biliary cirrhosis: a pilot
study. J Gastroenterol Hepatol 1999
Oct;14(10):1034-40.
324. Copp RP, et al. Localization of alpha-tocopherol
transfer protein in the brains of patients with ataxia with
vitamin E deficiency and other oxidative stress related
neurodegenerative disorders. Brain Res 1999 Mar
20;822(1-2):80-7.
325. Tanyel MC, et al. Neurologic findings in vitamin E
deficiency. Am Fam Physician 1997 Jan;55(1):197-201.
326.Arria AM, et al. Vitamin E deficiency and psychomotor
dysfunction in adults with primary biliary cirrhosis. Am J
Clin Nutr 1990 Aug;52(2):383-90.
327.Winklhofer-Roob BM, et al. Short-term changes in
erythrocyte alpha-tocopherol content of vitamin E-deficient
patients with cystic fibrosis. Am J Clin Nutr 1992
Jan;55(1):100-3.
328. Margolis S, et al. Nutritional management of plasma
lipid disorders. J Am Coll Nutr 1989;8
Suppl:33S-45S.
329. Jeffrey GP, et al. Vitamin E deficiency and its clinical
significance in adults with primary biliary cirrhosis and
other forms of chronic liver disease. J Hepatol 1987
Jun;4(3):307-17.
330. Perlmutter DH, et al. Intramuscular vitamin E repletion
in children with chronic cholestasis. Am J Dis Child 1987
Feb;141(2):170-4.
331. Knight RE, et al. Neurologic syndrome associated with
low levels of vitamin E in primary biliary cirrhosis.
Gastroenterology 1986 Jul;91(1):209-11.
332. Larsen PD, et al. Vitamin E deficiency associated with
vision loss and bulbar weakness. Ann Neurol 1985
Dec;18(6):725-7.
333. Machlin LJ.Clinical uses of vitamin E. Acta Vitaminol
Enzymol 1985;7 Suppl:33-43.
334. Morrow MJ Neurologic complications of vitamin E
deficiency: case report and review of the literature. Bull
Clin Neurosci 1985;50:53-60.
335. Saito K, et al. Pathology of chronic vitamin E
deficiency in fatal familial intrahepatic cholestasis (Byler
disease). Virchows Arch A Pathol Anat Histol 1982
Aug;396(3):319-30.
336. Rosenblum JL, et al. A progressive neurologic syndrome
in children with chronic liver disease. N Engl J Med 1981 Feb
26;304(9):503-8.
337. Franceschi S Nutrients and food groups and large bowel
cancer in Europe. Eur J Cancer Prev 1999 Dec;9 Suppl
1:S49-52.
338. Woodson K, et al. Serum alpha-tocopherol and subsequent
risk of lung cancer among male smokers. J Natl Cancer Inst
1999 Oct 20;91(20):1738-43.
339. Lopez-Carrillo L, et al. Nutrient intake and gastric
cancer in Mexico. Int J Cancer 1999 Nov
26;83(5):601-5.
340. Ronco A, et al. Dietary antioxidants and lung cancer
risk: a case-control study in Uruguay. Nutr Cancer
1999;34(1):100-10.
341. Yang CS Vitamin nutrition and gastroesophageal cancer. J
Nutr 2000 Feb;130(2S Suppl):338S-339S.
342. Ahmed MI, et al. Lipid peroxidation and antioxidant
status in human cervical carcinoma. Dis Markers 1999
Dec;15(4):283-91.
343. Elattar TM, et al. Biphasic action of vitamin E on the
growth of human oral squamous carcinoma cells. Anticancer Res
1999 Jan-Feb;19(1A):365-8.
344. Launoy G, et al. Diet and squamous-cell cancer of the
oesophagus: a French multicentre case-control study. Int J
Cancer 1998 Mar 30;76(1):7-12.
345. Bairati I, et al. [Prevention of second primary cancer
with vitamin supplementation in patients treated for head and
neck cancers]. Bull Cancer Radiother
1996;83(1):12-6.
346. El Attar TM, et al. Vitamin E succinate potentiates the
inhibitory effect of prostaglandins on oral squamous
carcinoma cell proliferation. Prostaglandins Leukot Essent
Fatty Acids 1995 Jan;52(1):69-73.
347. Gottlober P, et al. [The treatment of cutaneous
radiation-induced fibrosis with pentoxifylline and vitamin E.
An empirical report]. Strahlenther Onkol 1996
Jan;172(1):34-8.
348.Schwartz JL, et al. Altered cytokeratin expression in
carcinogenesis inhibition by antioxidant nutrients. Nutr
Cancer 1995;24(1):47-56.
349. ElAttar TM, et al. Inhibition of human oral squamous
carcinoma cell (SCC-25) proliferation by prostaglandin E2 and
vitamin E succinate. J Oral Pathol Med 1993
Oct;22(9):425-7.
350. Schwartz JL, et al. Molecular and biochemical
reprogramming of oncogenesis through the activity of
prooxidants and antioxidants. Ann N Y Acad Sci 1993 May
28;686:262-78; discussion 278-9.
351. Schwartz J, et al. The selective cytotoxic effect of
carotenoids and alpha-tocopherol on human cancer cell lines
in vitro. J Oral Maxillofac Surg 1992 Apr;50(4):367-73;
discussion 373-4.
352. ElAttar TM, et al. Inhibition of growth in oral squamous
carcinoma cells by cyclopentenone prostaglandins: comparison
with chemotherapeutic agents. Prostaglandins Leukot Essent
Fatty Acids 1997 Jun;56(6):461-5.
353. Klipstein-Grobusch K, et al. Dietary antioxidants and
risk of myocardial infarction in the elderly: the Rotterdam
Study. Am J Clin Nutr 1999 Feb;69(2):261-6.
354. Gey KF Vitamins E plus C and interacting conutrients
required for optimal health. A critical and constructive
review of epidemiology and supplementation data regarding
cardiovascular disease and cancer. Biofactors
1998;7(1-2):113-74.
355. Schroder H, et al. Nutrition antioxidant status and
oxidative stress in professional basketball players: effects
of a three compound antioxidative supplement. Int J Sports
Med 2000 Feb;21(2):146-50.
356. Welch RW, et al. Dietary antioxidant supplementation and
DNA damage in smokers and nonsmokers. Nutr Cancer
1999;34(2):167-72 .
357. Chen D, et al. [The inhibitory effects of antioxidant
vitamins on serum oxLDL and experimental atherosclerosis of
rabbits]. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1997
Dec;19(6):451-5.
358. Fillion L, et al. Beta-carotene enhances the recovery of
lymphocytes from oxidative DNA damage. Acta Biochim Pol
1998;45(1):183-90 .
359. Linselsen J., et al. Effect of a single oral dose of
antioxidant mixture (vitamin E, carotenoids) on the formation
of cholesterol oxidation products after ex vivo LDL oxidation
in humans. Eur J Med Res 1998 Feb 21;3(1-2):5-12.
360. Dixon ZR, et al. The effect of a low carotenoid diet on
malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations
in women: a placebo-controlled double-blind study. Eur J Med
Res 1998 Feb 21;3(1-2):5-12.
361. Sumida S, et al. Effect of a single bout of exercise and
beta-carotene supplementation on the urinary excretion of
8-hydroxy-deoxyguanosine in humans. Free Radic Res 1997
Dec;27(6):607-18.
362. Meraji S, et al. Enhanced plasma level of lipid
peroxidation in Iranians could be improved by antioxidants
supplementation. Eur J Clin Nutr 1997
May;51(5):318-25.
363. Omaye ST, et al. Blood antioxidants changes in young
women following beta-carotene depletion and repletion. J Am
Coll Nutr 1996 Oct;15(5):469-74.
364. Kanter MM, et al. Effects of an antioxidant vitamin
mixture on lipid peroxidation at rest and postexercise. J
Appl Physiol 1993 Feb;74(2):965-9.
365. Chao WH, et al. Oxidative stress in humans during work
at moderate altitude. J Nutr 1999
Nov;129(11):2009-12.
366. Bunout D, et al. Effects of supplementation with folic
acid and antioxidant vitamins on homocysteine levels and LDL
oxidation in coronary patients. Nutrition 2000
Feb;16(2):107-10.
367. Lee BM, et al. Inhibition of oxidative DNA damage,
8-OHdG, and carbonyl contents in smokers treated with
antioxidants (vitamin E, vitamin C, beta-carotene and red
ginseng). Cancer Lett 1998 Oct 23;132(1-2):219-27.
368. Howard DJ, et al. Oxidative stress induced by
environmental tobacco smoke in the workplace is mitigated by
antioxidant supplementation. Cancer Epidemiol Biomarkers Prev
1998 Nov;7(11):981-8.
369. Porrini M, et al. Lymphocyte lycopene concentration and
DNA protection from oxidative damage is increased in women
after a short period of tomato consumption. J Nutr 2000
Feb;130(2):189-92.
370. Steinberg FM, et al. Antioxidant vitamin supplementation
and lipid peroxidation in smokers. Am J Clin Nutr 1998
Aug;68(2):319-27 Published erratum appears in Am J Clin Nutr
1999 Jun;69(6):1293.
371. Stahl W, et al. Carotenoid mixtures protect
multilamellar liposomes against oxidative damage: synergistic
effects of lycopene and lutein. FEBS Lett 1998 May
8;427(2):305-8.
372. Fleshner NE, et al. Diet, androgens, oxidative stress
and prostate cancer susceptibility. Cancer Metastasis Rev
1998-99;17(4):325-30.
373. Rao AV, et al. Serum and tissue lycopene and biomarkers
of oxidation in prostate cancer patients: a case-control
study. Nutr Cancer 1999;33(2):159-64.
374. Riso P, et al.Does tomato consumption effectively
increase the resistance of lymphocyte DNA to oxidative
damage? Am J Clin Nutr 1999 Apr;69(4):712-8.
375. Lowe GM, et al. Lycopene and beta-carotene protect
against oxidative damage in HT29 cells at low concentrations
but rapidly lose this capacity at higher doses. Free Radic
Res 1999 Feb;30(2):141-51.
376. Stahl W, et al. Carotenoids and carotenoids plus vitamin
E protect against ultraviolet light-induced erythema in
humans. Am J Clin Nutr 2000 Mar;71(3):795-8.
377. Blot WJ. Vitamin/mineral supplementation and cancer
risk: international chemoprevention trials. Proc Soc Exp Biol
Med 1997 Nov;216(2):291-6.
378. Kerstin Klipstein-Grobusch, et al. Original Research
Communications Dietary antioxidants and risk of myocardial
infarction in the elderly: the Rotterdam Study1,2,3 American
Journal of Clinical Nutrition, Vol. 69, No. 2, 261-266,
February 1999.
379. Anderson JW, et al. Antioxidant supplementation effects
on low-density lipoprotein oxidation for individuals with
type 2 diabetes mellitus. Am Coll Nutr 1999
Oct;18(5):451-61.
380. Gann PH, et al. Lower prostate cancer risk in men with
elevated plasma lycopene levels: results of a prospective
analysis. Cancer Res 1999 Mar 15;59(6):1225-30.
381. Murata M, et al. Oxidative DNA damage by vitamin A and
its derivative via superoxide generation. J Biol Chem 2000
Jan 21;275(3):2003-8.
382. Knekt P, et al. Serum antioxidant vitamins and risk of
cataract. BMJ 1992 Dec 5;305(6866):1392-4.
383. Riedl J, et al. Some dietary fibers reduce the
absorption of carotenoids in women. J Nutr 1999
Dec;129(12):2170-6.
384. Castenmiller JJ, et al. beta-carotene does not change
markers of enzymatic and nonenzymatic antioxidant activity in
human blood. J Nutr 1999 Dec;129(12):2162-9.
385. Speizer FE, et al. Prospective study of smoking,
antioxidant intake, and lung cancer in middle-aged women
(USA). Cancer Causes Control 1999 Oct;10(5):475-82.
386. Ascherio A, et al. Relation of consumption of vitamin E,
vitamin C, and carotenoids to risk for stroke among men in
the United States. Ann Intern Med 1999 Jun
15;130(12):963-70.
387. Shaish A, et al. Dietary beta-carotene and
alpha-tocopherol combination does not inhibit atherogenesis
in an ApoE-deficient mouse model. Arterioscler Thromb Vasc
Biol 1999 Jun;19(6):1470-5.
388. Lugli SM, et al. Stimulation of cell division in the rat
by NaCl, KCl, MgCl2, and CaCl2, and inhibition of the sodium
chloride effect on the glandular stomach by ascorbic acid and
beta-carotene. J Cancer Res Clin Oncol
1999;125(3-4):209-13.
389. Girodon F, et al. Impact of trace elements and vitamin
supplementation on immunity and infections in
institutionalized elderly patients: a randomized controlled
trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999
Apr 12;159(7):748-54.
390. West KP Jr, et al. Double blind, cluster randomised
trial of low dose supplementation with vitamin A or
beta-carotene on mortality related to pregnancy in Nepal. The
NNIPS-2 Study Group. BMJ 1999 Feb
27;318(7183):570-5.
391. Faulks RM, et al. Changes in plasma carotenoid and
vitamin E profile during supplementation with oil palm fruit
carotenoids. J Lab Clin Med 1998 Dec;132(6):507-11.
392. Romieu I, et al. Antioxidant supplementation and
respiratory functions among workers exposed to high levels of
ozone. Am J Respir Crit Care Med 1998
Jul;158(1):226-32.
393. Mark SD, et al. Do nutritional supplements lower the
risk of stroke or hypertension? Epidemiology 1998
Jan;9(1):9-15.
394. Johnson MA, et al. Micronutrient supplementation and
infection in institutionalized elders. Nutr Rev 1997
Nov;55(11 Pt 1):400-4.
395. Longnecker MP, et al. Intake of carrots, spinach, and
supplements containing vitamin A in relation to risk of
breast cancer. Cancer Epidemiol Biomarkers Prev 1997
Nov;6(11):887-92.
396. Patterson RE, et al. Vitamin supplements and cancer
risk: the epidemiologic evidence. Cancer Causes Control 1997
Sep;8(5):786-802.
397. Tsubono Y, et al. A randomized controlled trial for
chemoprevention of gastric cancer in high-risk Japanese
population; study design, feasibility and protocol
modification. Jpn J Cancer Res 1997
Apr;88(4):344-9.
398. Coodley GO, et al. Beta-carotene in HIV infection: an
extended evaluation. AIDS 1996 Aug;10(9):967-73.
399. Zondervan KT, et al. Do dietary and supplementary
intakes of antioxidants differ with smoking status? Int J
Epidemiol 1996 Feb;25(1):70-9.
400. Iyama T, et al. beta-Carotene accumulation in mouse
tissues and a protective role against lipid peroxidation. Int
J Vitam Nutr Res 1996;66(4):301-5.
401. Weisburger JH Evaluation of the evidence on the role of
tomato products in disease prevention. Proc Soc Exp Biol Med
1998 Jun;218(2):140-3.
402. Peng YM, et al. Concentrations of carotenoids,
tocopherols, and retinol in paired plasma and cervical tissue
of patients with cervical cancer, precancer, and noncancerous
diseases. Cancer Epidemiol Biomarkers Prev 1998
Apr;7(4):347-50.
403. Garewal HS, et al. Emerging role of beta-carotene and
antioxidant nutrients inprevention of oral cancer. Arch
Otolaryngol Head Neck Surg 1995 Feb;121(2):141-4.
404. Buring JE, et al. beta-carotene and cancer
chemoprevention. J Cell Biochem Suppl
1995;22:226-30.
405. Taylor PR, et al. Prevention of esophageal cancer: the
nutrition intervention trials in Linxian, China. Linxian
Nutrition Intervention Trials Study Group. Cancer Res 1994
Apr 1;54(7 Suppl):2029s -2031s.
406. Kardinaal AF, et al. Antioxidants in adipose tissue and
risk of myocardial infarction: the EURAMIC Study. Lancet 1993
Dec 4;342(8884):1379-84.
407. Park E, et al. Effects of multivitamin/mineral
supplementation, at nutritional doses, on plasma antioxidant
status and DNA damage estimated by sister chromatid exchanges
in lymphocytes in pregnant women. Int J Vitam Nutr Res 1999
Nov;69(6):396-402.
408. Wang XD, et al. Procarcinogenic and anticarcinogenic
effects of beta-carotene. Nutr Rev 1999 Sep;57(9 Pt
1):263-72.
409. Hughes DA Effects of carotenoids on human immune
function. Proc Nutr Soc 1999 Aug;58(3):713-8.
410. Stefani ED, et al. Dietary antioxidants and lung cancer
risk: a case-control study in Uruguay. Nutr Cancer
1999;34(1):100-10.